ACADIA Pharmaceuticals, Inc. (ACAD)
18.27
+1.77
(+10.73%)
USD |
NASDAQ |
Nov 10, 16:00
18.19
-0.08
(-0.44%)
After-Hours: 20:00
ACADIA Pharmaceuticals Cash from Operations (Annual) : 109.84M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 109.84M |
| December 31, 2024 | 157.72M |
| December 31, 2023 | 16.70M |
| December 31, 2022 | -114.04M |
| December 31, 2021 | -125.66M |
| December 31, 2020 | -136.17M |
| December 31, 2019 | -151.13M |
| December 31, 2018 | -167.47M |
| December 31, 2017 | -217.76M |
| December 31, 2016 | -208.41M |
| December 31, 2015 | -121.42M |
| December 31, 2014 | -66.43M |
| December 31, 2013 | -31.77M |
| Date | Value |
|---|---|
| December 31, 2012 | -21.63M |
| December 31, 2011 | -19.90M |
| December 31, 2010 | -10.70M |
| December 31, 2009 | -13.73M |
| December 31, 2008 | -64.87M |
| December 31, 2007 | -54.93M |
| December 31, 2006 | -41.42M |
| December 31, 2005 | -20.26M |
| December 31, 2004 | -20.69M |
| December 31, 2003 | -9.816M |
| December 31, 2002 | -9.243M |
| December 31, 2001 | -11.29M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ionis Pharmaceuticals, Inc. | -268.58M |
| Arcturus Therapeutics Holdings, Inc. | -74.27M |
| ADMA Biologics, Inc. | 50.40M |
| Immunic, Inc. | -85.81M |
| Viking Therapeutics, Inc. | -278.68M |